Speaker Profile: Martin Sharpless, AIA
Martin Sharpless, AIA is the Capital Projects Director in charge of R&D facilities capital programs for multiple US and UK locations, at AstraZeneca Pharmaceuticals LP. He is responsible for executing capital projects and portfolio management at the growing MedImmune R&D campus in Gaithersburg, MD and other AZ sites globally. Martin developed the $54 M AZ site in South San Francisco, CA and led components of the new $1B+ AZ corporate headquarters in Cambridge, UK. Martin is part of the Global Engineering organization at AZ. AstraZeneca is a global, innovation-driven biopharmaceutical business that operates in over 100 countries, with medicines used by millions of patients worldwide.
Martin has experience with highly sustainable and resilient project design, construction, design build, development projects and public private partnerships (P3) project delivery. Martin was previously Vice President with Skanska USA Building Inc. and Gilbane Building Company respectively, providing Principal-level client, AEC and P3 partner leadership since 1998. Prior to his construction career Martin, a registered architect, was an Associate with Kling Stubbins in Philadelphia and Washington, DC. He started his career at Ballinger Architects, and earned a Bachelor of Science and Bachelor of Architecture at Pennsylvania State University.